AMAG Pharmaceuticals, Inc. (AMAG) Misses Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Total costs and expenses: 105.02M
Today's EPS Names:
JBLU, SICP, OMID, More
Financial Fact:
Total costs and expenses: 105.02M
Today's EPS Names:
JBLU, SICP, OMID, More
Join SI Premium – FREE
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) reported Q1 EPS of ($1.05), $0.03 worse than the analyst estimate of ($1.02). Revenue for the quarter came in at $13.4 million versus the consensus estimate of $15.25 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H2O America (HTO) Misses Q3 EPS by 16c ; Offers Guidance
- Five Star Bancorp (FSBC) Tops Q3 EPS by 7c
- Novartis (NVS) Tops Q3 EPS by 18c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
